Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure: An Exploratory Proof-of-Concept Trial.

Autor: Chowdary, Pratima1,2 (AUTHOR) p.chowdary@ucl.ac.uk, Agarwal, Banwari3 (AUTHOR), Peralta, Maria Rita1,2 (AUTHOR), Bhagani, Sanjay4 (AUTHOR), Lee, Simon4 (AUTHOR), Goldring, James5 (AUTHOR), Lipman, Marc5,6 (AUTHOR) simon.brill@nhs.net, Waqif, Emal1 (AUTHOR), Phillips, Mark1,2 (AUTHOR), Philippou, Helen7 (AUTHOR), Foley, Jonathan H.8 (AUTHOR), Mutch, Nicola J.9 (AUTHOR), Ariëns, Robert A. S.7 (AUTHOR), Stringer, Kathleen A.10,11 (AUTHOR), Ricciardi, Federico12 (AUTHOR), Watissée, Marie13 (AUTHOR), Hughes, Derralynn2 (AUTHOR), Nathwani, Amit1,2 (AUTHOR), Riddell, Anne1,14 (AUTHOR), Patch, David15 (AUTHOR)
Zdroj: Journal of Clinical Medicine. Sep2023, Vol. 12 Issue 18, p5848. 17p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje